Alpha Therapeutic Services

Alpha Therapeutic Corporation was a prominent manufacturer of plasma-derived therapeutic products, specializing in treatments for rare and chronic conditions such as hemophilia and alpha-1 antitrypsin deficiency. Headquartered in Los Angeles, the company operated as a subsidiary of the Japanese firm Green Cross Corporation and was a pioneer in implementing safety measures like heat treatment and solvent-detergent processes for blood products. In 2002, the company's assets were acquired by the Spanish healthcare giant Grifols, a move that significantly expanded Grifols' footprint in the United States. Historically, the company is also known for its involvement in the complex litigation surrounding the transmission of HIV and Hepatitis C through plasma products during the 1980s.